2017
DOI: 10.7150/jbji.16448
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Periprosthetic Joint Infection Using Antimicrobials: Dilute Povidone-Iodine Lavage

Abstract: Periprosthetic joint infections (PJI) remain a challenge for the orthopaedic surgeon to treat and remain a leading cause of failure of both primary and revision total joint arthroplasty. Once a PJI develops, surgical treatment is generally indicated and includes an aggressive irrigation and debridement. One component of the irrigation and debridement involves the use of an antiseptic irrigating solution. In primary and revision TJA, dilute povidone-iodine lavage can be performed prior to wound closure. Approxi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
58
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 69 publications
(59 citation statements)
references
References 33 publications
0
58
0
1
Order By: Relevance
“…Such low cure rates are believed to occur in part due to surgeon variability in how surgical debridement is performed, but also due to current topical agents being ineffective in removing biofilm from metal and plastic implant surfaces [30]. Currently, administration of dilute betadine [31], chlorhexidine [32], and vancomycin powder [33] has all been separately advocated to improve irrigation and debridement treatment outcomes, but these effects have only been observed in retrospective case series. The limited quality of evidence and high degree of both morbidity and mortality obviate the need for novel methods of preventing and eradicating biofilm formation around artificial joint implants.…”
Section: Why Do Contemporary Treatments Fail?mentioning
confidence: 99%
“…Such low cure rates are believed to occur in part due to surgeon variability in how surgical debridement is performed, but also due to current topical agents being ineffective in removing biofilm from metal and plastic implant surfaces [30]. Currently, administration of dilute betadine [31], chlorhexidine [32], and vancomycin powder [33] has all been separately advocated to improve irrigation and debridement treatment outcomes, but these effects have only been observed in retrospective case series. The limited quality of evidence and high degree of both morbidity and mortality obviate the need for novel methods of preventing and eradicating biofilm formation around artificial joint implants.…”
Section: Why Do Contemporary Treatments Fail?mentioning
confidence: 99%
“…However, there are no guidelines in cases of unexpected sterility errors. Treating infection at the surgical site is a constant challenge in orthopedic surgery, and remains a leading cause of failure, with increased morbidity and mortality rates 8. Despite continued efforts in research, education and technical progress, per-operative contamination remains relatively frequent.…”
Section: Discussionmentioning
confidence: 99%
“…Due to obvious methodological limitations one can only extrapolate from non-dedicated studies. Ruder et al 8 found that lavage of the contaminated implant reduced the risk of deep surgical site infection in orthopedic surgery, when using dilute povidone- iodine lavage prior to wound closure. As this chemical has no associated adverse effects, they concluded that this method is a safe and inexpensive method to reduce the infection rate.…”
Section: Discussionmentioning
confidence: 99%
“…Similar to other antiseptic irrigation efficacy studies, the broad-spectrum effects of CHG have been highlighted in in vitro studies. CHG solutions have been shown to decrease MRSA biofilm load (Schwechter et al, 2011) and Staphylococcus epidermidis biofilm (Frisch et al, 2017) on orthopaedic implants using a titanium alloy (Ti-6Al-4V) in vitro models. Clinically, Barros et al ( 2019) noted an 89.5 % (34 out of 38) success rate using a CHG scrub brush followed by normal saline irrigation in a DAIR (12 THA, 12 TKA) protocol at 2-year follow-up.…”
Section: Clinical Outcomesmentioning
confidence: 99%